Stocks and Investing Stocks and Investing
Thu, March 9, 2023
Wed, March 8, 2023
Tue, March 7, 2023

Mason Carrico Downgraded (CDNA) to Hold and Decreased Target to $9 on, Mar 7th, 2023


Published on 2024-10-28 02:08:41 - WOPRAI, Mason Carrico
  Print publication without navigation


Mason Carrico of Stephens & Co., Downgraded "CareDx, Inc" (CDNA) to Hold and Decreased Target from $19 to $9 on, Mar 7th, 2023.

Mason has made no other calls on CDNA in the last 4 months.



There are 3 other peers that have a rating on CDNA. Out of the 3 peers that are also analyzing CDNA, 2 agree with Mason's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Alexander Nowak of "Craig-Hallum" Downgraded from Strong Buy to Hold and Decreased Target to $9 on, Friday, March 3rd, 2023
  • Andrew Cooper of "Raymond James" Downgraded from Strong Buy to Hold and Held Target at $24 on, Friday, March 3rd, 2023


This is the rating of the analyst that currently disagrees with Mason


  • Mark Massaro of "BTIG" Maintained at Strong Buy with Decreased Target to $25 on, Tuesday, February 28th, 2023